Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...
A comprehensive product overview including the AIRSUPRA description, mechanism of action, dosage and administration, research and development activities in Asthma. Elaborated details on AIRSUPRA ...
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...
5.3.2. Market Size of AIRSUPRA in Germany for Asthma 5.3.3. Market Size of AIRSUPRA in France for Asthma 5.3.4. Market Size of AIRSUPRA in Italy for Asthma 5.3.5. Market Size of AIRSUPRA in Spain ...
A comprehensive product overview including the AIRSUPRA description, mechanism of action, dosage and administration, research and development activities in Asthma. Elaborated details on AIRSUPRA ...
Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "AIRSUPRA Market Size, Insight, and Forecast to 2032" report has been added to ResearchAndMarkets.com's offering. This report provides comprehensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results